Cancer Research

CAR T cell therapy leads to lasting remissions

In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor CAR T cell therapy Kymriah® led to long-lasting remissions in patients with non-Hodgkins lymphoma.

Penn Today Staff



Media Contact


Experts



In the News


HealthDay News

For Breast Cancer Patients, Less Time on Hormonal Meds?

Susan Domchek of the Perelman School of Medicine and the Abramson Cancer Center comments on hormonal therapy.

FULL STORY →



Nature

Acupuncture in Cancer Study Reignites Debate About Controversial Technique

Rollin Gallagher of the Perelman School of Medicine comments on a clinical trial that focused on whether acupuncture can relieve pain in cancer patients.

FULL STORY →